AFMD Affimed NV Year-over-year net earnings per share growth for the last 12 months
Affimed development relies on the success of clinical trials against lymphomas and strict control of R&D costs. The current quarterly EPS trend confirms this momentum, where 0.00 shows the value of this parameter. Patents for bispecific activators and alliances with industry behemoths guarantee stability, while diversification across various immunotherapy programs minimizes specific oncological risks.
AFMD (Affimed): analytical breakdowns and indicator data
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
- earnings and market multiples details:
AFMD - Net Income|Projected Future Earnings Affimed|AFMD - Market Cap to Earnings|Forward P/E Multiple affimed.com|AFMD - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Affimed Therapeutics|AFMD - Operating profit EBITDA|Net earnings per share (EPS TTM) Affimed|AFMD - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months affimed.com|AFMD - Net earnings per share growth this year|Earnings growth forecast for next year Affimed
General company analysis:Affimed NV - AFMD
The expansion of the Affimed (AFMD) ROCK platform within the immunopharmaceuticals segment requires colossal clinical trial expenditures, which directly impacts net earnings per share. The trend of this metric measures the percentage change in EPS between quarters, revealing the actual efficiency of capital management; therefore, analyzing quarterly EPS growth allows for the determination of whether critical costs are hidden behind the scaling of the business.
Competing companies
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|CLDX - Quarterly EPS earnings growth|AUPH: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months BCRX (biocryst.com)|VERA (Vera Therapeutics) - Quarterly EPS earnings growth|Dianthus Therapeutics Inc - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth PHVS|Year-over-year net earnings per share change for the last twelve months AbCellera Bio|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio, Inc. TRML|PGEN - Year-over-year net earnings per share growth for the last 12 months|Pharming Group - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Nektar Therapeutics Inc|UPB: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months ZBIO|IMNM (Immunome, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth gossamerbio.com|Quarterly EPS earnings growth KALV|SEPN: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals Inc PVLA|SVRA - Year-over-year net earnings per share growth for the last 12 months|Rigel Pharmaceuticals - Quarterly EPS earnings growth|ANAB (anaptysbio.com) - Year-over-year earnings per share growth for the last 12 months|Astria Therapeutics, Inc. (ATXS) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ENGN (enGene Holdings Inc)|RAPT (RAPT Therapeutics) - Quarterly EPS earnings growth|JBIO: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACRS|Quarterly EPS earnings growth kyvernatx.com (KYTX)|Year-over-year earnings per share growth for the last twelve months Tiziana Life Sciences Ltd TLSA|Year-over-year earnings per one share growth for the last 12 months CABA|VTYX - Year-over-year earnings per share growth for the last twelve months|Theratechnologies, Inc (THTX) - Year-over-year net earnings per share growth for the last 12 months|AVTX: Quarterly EPS earnings growth|eledon.com (ELDN) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months AGEN|CLYM: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ZURA|Year-over-year net earnings per share change for the last twelve months aTyr Pharmaceuticals|Year-over-year earnings per share growth for the last twelve months Adagene Inc. ADAG|IMA - Year-over-year net earnings per share growth for the last 12 months|STTK - Year-over-year earnings per share growth for the last twelve months|Equillium, Inc. (EQ) - Year-over-year net earnings per share growth for the last 12 months|CNTB (connectbiopharm.com) - Year-over-year net earnings per share growth for the last 12 months|Immunic (IMUX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Atara Biotherapeutics, Inc.|Year-over-year earnings per share growth for the last 12 months IFRX (InflaRx GmbH)|Quarterly EPS earnings growth XFOR|ACET - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth CELU (Celularity)|Quarterly EPS earnings growth INmune Bio Corporation INMB|Barinthus Biotherapeutics - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months KZR|SABS: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months AKTX (Akari Therapeutics PLC)|ENLV (Enlivex Therapeutics Ltd) - Quarterly EPS earnings growth|Q32 Bio Corp (QTTB) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months GeoVax Labs, Inc. (GOVX)|Year-over-year net earnings per share growth for the last 12 months edesabiotech.com EDSA|Quarterly EPS earnings growth IBIO (iBio)|Carisma Therapeutics Inc (CARM) - Earnings per share growth in annualized terms for the last twelve months|XTL Biopharmaceuticals, Ltd. - Quarterly EPS earnings growth|BOLT (Bolt Biotherapeutics) - Year-over-year earnings per share growth for the last 12 months|HCWB: Quarterly EPS earnings growth|Aptevo Therapeutics Inc. (APVO) - Quarterly EPS earnings growth|AIM (AIM ImmunoTech Inc.) - Quarterly EPS earnings growth|Aditxt Corp - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months GRI Bio Corp (GRI)|Year-over-year net earnings per share growth for the last 12 months XORTX Corp XRTX|Quarterly EPS earnings growth HIND (Vyome Holdings Inc)|REVB: Year-over-year earnings per share growth for the last 12 months|INDP - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months SCNI|CALI: Quarterly EPS earnings growth|Allakos - Year-over-year earnings per one share growth for the last 12 months|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth IGM Bio|Year-over-year earnings per share growth for the last twelve months iTeos Therapeutics, Inc. (ITOS)|OCEA (Ocean Biomedical Inc) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months TC BioPharm (Holdings) PLC TCBP|THRD - Year-over-year net earnings per share growth for the last 12 months
